These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8735363)

  • 1. Hormone replacement therapy in a risk-benefit perspective.
    Daly E; Vessey MP; Barlow D; Gray A; McPherson K; Roche M
    Maturitas; 1996 Mar; 23(2):247-59. PubMed ID: 8735363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Risks, benefits and costs of hormone replacement therapy in menopause].
    Gaspard U
    Rev Med Liege; 1998 May; 53(5):298-304. PubMed ID: 9689887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HRT: an analysis of benefits, risks and costs.
    Daly E; Roche M; Barlow D; Gray A; McPherson K; Vessey M
    Br Med Bull; 1992 Apr; 48(2):368-400. PubMed ID: 1450876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone replacement therapy: II. A pharmacoeconomic appraisal of its role in the prevention of postmenopausal osteoporosis and ischaemic heart disease.
    Whittington R; Faulds D
    Pharmacoeconomics; 1994 Jun; 5(6):513-54. PubMed ID: 10147266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cost-effectiveness analysis of hormone replacement therapy in the menopause.
    Cheung AP; Wren BG
    Med J Aust; 1992 Mar; 156(5):312-6. PubMed ID: 1588862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of hormone replacement therapy after the menopause.
    Tosteson AN; Weinstein MC
    Baillieres Clin Obstet Gynaecol; 1991 Dec; 5(4):943-59. PubMed ID: 1822828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen use in postmenopausal women--costs, risks, and benefits.
    Weinstein MC
    N Engl J Med; 1980 Aug; 303(6):308-16. PubMed ID: 6770270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost effectiveness of hormone therapy in women at high risks of fracture in Sweden, the US and the UK--results based on the Women's Health Initiative randomised controlled trial.
    Lekander I; Borgström F; Ström O; Zethraeus N; Kanis JA
    Bone; 2008 Feb; 42(2):294-306. PubMed ID: 18053789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone replacement therapy: I. A pharmacoeconomic appraisal of its therapeutic use in menopausal symptoms and urogenital estrogen deficiency.
    Whittington R; Faulds D
    Pharmacoeconomics; 1994 May; 5(5):419-45. PubMed ID: 10147233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution.
    Norman RJ; Flight IH; Rees MC
    Cochrane Database Syst Rev; 2000; (2):CD001018. PubMed ID: 10796730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone replacement therapy and the breast.
    Dixon JM
    Surg Oncol; 2003 Dec; 12(4):251-63. PubMed ID: 14998565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone replacement therapy is associated with improved arterial physiology in healthy post-menopausal women.
    McCrohon JA; Adams MR; McCredie RJ; Robinson J; Pike A; Abbey M; Keech AC; Celermajer DS
    Clin Endocrinol (Oxf); 1996 Oct; 45(4):435-41. PubMed ID: 8959082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The menopause: benefits and risks of estrogen-progestogen replacement therapy.
    Gambrell RD
    Fertil Steril; 1982 Apr; 37(4):457-74. PubMed ID: 7040116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of hormone replacement therapy for fracture prevention in young postmenopausal women: an economic analysis based on a prospective cohort study.
    Fleurence R; Torgerson DJ; Reid DM
    Osteoporos Int; 2002 Aug; 13(8):637-43. PubMed ID: 12181622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Menopausal hormone therapy: a systematic review of cost-effectiveness evaluations.
    Velentzis LS; Salagame U; Canfell K
    BMC Health Serv Res; 2017 May; 17(1):326. PubMed ID: 28476121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Back to the future: Hormone replacement therapy as part of a prevention strategy for women at the onset of menopause.
    Lobo RA; Pickar JH; Stevenson JC; Mack WJ; Hodis HN
    Atherosclerosis; 2016 Nov; 254():282-290. PubMed ID: 27745704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A computer model to analyze the cost-effectiveness of hormone replacement therapy.
    Zethraeus N; Johannesson M; Jönsson B
    Int J Technol Assess Health Care; 1999; 15(2):352-65. PubMed ID: 10507194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of endogenous and exogenous hormones on breast cancer: epidemiology.
    Vessey MP
    Verh Dtsch Ges Pathol; 1997; 81():493-501. PubMed ID: 9474890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The management of menopause in women with a history of endometriosis: a systematic review.
    Gemmell LC; Webster KE; Kirtley S; Vincent K; Zondervan KT; Becker CM
    Hum Reprod Update; 2017 Jul; 23(4):481-500. PubMed ID: 28498913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.